Clinical Trial Update: Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for TX000045 in participants with pulmonary hypertension due to interstitial lung disease; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• TX000045

Snippet

Sponsor: Tectonic Operating Company, Inc. | Conditions: Hypertension, Pulmonary, Lung Diseases, Interstitial | Phase 2 | Status: NOT_YET_RECRUITING